Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Open Angle Glaucoma (OAG): early-phase trial registry
5 of 6 indexed Open Angle Glaucoma (OAG) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Open Angle Glaucoma (OAG): 6 US clinical trials tracked, 5 recruiting.
Open Angle Glaucoma (OAG) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Life Biosciences, running 1 of these trials.
Enrollment posture brief
Registry condition open-angle-glaucoma-oag
OPEN 5 | RECR 83% | LATE 0 | EARLY 3 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Open Angle Glaucoma (OAG) lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Open Angle Glaucoma (OAG) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Open Angle Glaucoma (OAG) is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Open Angle Glaucoma (OAG) research.
Life Biosciences accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Open Angle Glaucoma (OAG) trials plan to enrol fewer than 100 people.
Median target enrolment is 55 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Open Angle Glaucoma (OAG) splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Avisi Technologies
NCT07220876
DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
Barnet Dulaney Perkins Eye Centers
NCT06933836
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Glaukos Corporation
NCT07400926
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Life Biosciences
NCT07290244
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Qlaris Bio
NCT07354477
Travoprost Five Day Posology Study
Alcon Research
NCT01114893
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Open Angle Glaucoma (OAG) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Open Angle Glaucoma (OAG) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Open Angle Glaucoma (OAG) page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Open Angle Glaucoma (OAG) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Life Biosciences sponsors the most Open Angle Glaucoma (OAG) trials on record, review their full trial history before evaluating a specific study. See Life Biosciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Open Angle Glaucoma (OAG) condition card totals 6 registered trials; most-linked intervention Travoprost (Groups A, B and C); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.